Enesi Pharma Enters Agreement with NIH to Evaluate ImplaVax-enabled Flu Vaccines
19 Oct 2021 //
PRNEWSWIRE
Enesi Pharma to Present at World Vaccine Congress 2021 Virtual Meeting
27 Apr 2021 //
PRNEWSWIRE
Enesi & Imperial College London Collaborate to Develop RNA Vaccines
18 Dec 2020 //
PRNEWSWIRE
Enesi Pharma`s ImplaVax® Solid-Dose and Needle-Free Vaccination Platform
01 Oct 2020 //
PRNEWSWIRE
Enesi Pharma Partners with The University of Adelaide
08 Sep 2020 //
CONTRACT PHARMA
Enesi Pharma Partners with The University of Adelaide
04 Sep 2020 //
CONTRACTPHARMA
Enesi Pharma to Develop Thermostable Solid Dose DNA Vaccine Targeting Zika Virus
02 Sep 2020 //
PRNEWSWIRE
Enesi Gets Innovate UK Funding for Aseptic Mfg.
25 Sep 2019 //
CONTRACTPHARMA
Enesi`s Secures Innovate UK Funding to Enable Scalable Aseptic Mfg of ImplaVax®
23 Sep 2019 //
PR NEWSWIRE
Enesi Pharma adds Global Vaccine and Infectious Disease Expert Steven Chatfield to its Scientific Advisory Board
01 Jul 2019 //
PRESS RELEASE
Enesi Pharma & BARDA Drive Enter Public-Private Partnership to Develop ImplaVax®
15 Apr 2019 //
PR NEWSWIRE
Enesi Pharma & Public Health England Enter R&D Collaboration
01 Oct 2018 //
PRESS RELEASE